PERSISTENT KINASE SIGNALS IN PC12 CELL DIFFERENTIATION
PC12 细胞分化中的持续激酶信号
基本信息
- 批准号:3469039
- 负责人:
- 金额:$ 9.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1993
- 资助国家:美国
- 起止时间:1993-08-01 至 1998-07-31
- 项目状态:已结题
- 来源:
- 关键词:PC12 cells SDS polyacrylamide gel electrophoresis biological signal transduction cell differentiation cell growth regulation enzyme activity enzyme substrate fibroblast growth factor growth factor receptors immunoprecipitation neurotrophic factors phosphorylation platelet derived growth factor protein tyrosine kinase receptor expression western blottings
项目摘要
The long-term goal of this proposal is to define the specific effector
enzymes and protein kinases involved in growth factor receptor-regulated
cell differentiation and growth. As a model system the PC12
pheochromocytoma cell line reversibly responds to nerve growth factor
(NGF) and basic fibroblast growth factor (bFGF) with partial growth arrest
in G1 and neurite extension while epidermal growth factor (EGF) and
insulin-like growth factor-I (IGF-I) fail to induce differentiation and
instead, exert modest mitogenic actions. All of these growth factors
signal through membrane-bound receptor tyrosine kinases. To date, the
specific signals that distinguish the differentiation action of NGF and
bFGF from the mitogenic actions of EGF and IGF-I remain poorly defined.
Recent findings in this lab indicate that the p42/44 mitogen-activated
protein (MAP) kinases are persistently activated and tyrosine
phosphorylated by growth factors that direct differentiation while
mitogens cause only transient activation of the pathway. Based on this
finding and the requirement for constant growth factor exposure to
maintain the differentiated PC12 cell phenotype, this proposal will test
the hypothesis that persistent activation of specific effector enzymes and
protein kinases discriminates those growth factors that induce
differentiation from those that exert mitogenic actions in PC12 cells. The
specific aims of the project are to l) identify the effector enzymes (GAP,
P13-K, PLCgamma, etc.) required for induction of PC12 cell differentiation
using mutant human PDGF receptors that lack the ability to activate one or
more effector enzymes. The betaPDGF receptor is a receptor tyrosine kinase
that is absent in parental PC12 cells, but directs reversible neurite
outgrowth, partial growth arrest and persistent MAP kinase activation
similar to NGF and bFGF when stably transfected into the cells. This
permits a molecular genetic strategy to dissect the elements of growth
factor receptor signal transduction involved in PC12 cell differentiation.
This proposal also seeks to 2) define the mechanism by which NGF, bFGF and
PDGF stimulate persistent phosphorylation and activation of the p42/44 MAP
kinases in differentiating PC12 cells. Recombinant p42 MAP kinase will be
used as a protein kinase substrate to identify and assay protein kinases
that phosphorylate and activate the MAP kinases. Also, the p54 MAP kinase
and p34-cdc2 protein kinases which are related to the p42/44 MAP kinases
will be examined for differential regulation by neurotrophic factors and
mitogens. Finally, 3) mutated forms of p42 MAP kinase that may exhibit
dominant-negative phenotypes will be expressed in PC12 cells to ascertain
the requirement for p42/44 MAP kinases in growth factor signalling of PC12
cell differentiation. Together, these aims will begin to define the
network of effectors and protein kinases that transduce the receptor
tyrosine kinase-stimulated signals in PC12 cells resulting in cell growth
and differentiation.
这项提案的长期目标是定义特定的效应器
参与生长因子受体调节的酶和蛋白激酶
细胞分化和生长。作为一个模型系统,
嗜铬细胞瘤细胞系对神经生长因子的可逆反应
(NGF)和碱性成纤维细胞生长因子(bFGF),
在G1期和神经突延伸,而表皮生长因子(EGF)和
胰岛素样生长因子-I(IGF-I)不能诱导分化,
而是发挥适度的促有丝分裂作用。所有这些生长因子
通过膜结合受体酪氨酸激酶发出信号。迄今为止
区分NGF的分化作用的特异性信号,
EGF和IGF-I的促有丝分裂作用的bFGF仍然不清楚。
本实验室的最新发现表明,p42/44丝裂原活化
蛋白质(MAP)激酶持续激活,酪氨酸
被生长因子磷酸化,指导分化,
有丝分裂原仅引起该途径的短暂激活。基于此
发现和恒定生长因子暴露的要求
维持分化的PC 12细胞表型,该提案将测试
这一假说认为特异性效应酶的持续激活和
蛋白激酶区分那些诱导
与那些在PC 12细胞中发挥促有丝分裂作用的细胞分化。的
该项目的具体目标是1)鉴定效应酶(GAP,
P13-K、PLC γ等)诱导PC 12细胞分化所需的
使用突变的人PDGF受体,该受体缺乏激活一种或多种细胞因子的能力,
更多的效应酶β PDGF受体是一种受体酪氨酸激酶
在亲本PC 12细胞中不存在,但指导可逆的神经突
生长、部分生长停滞和持续性MAP激酶激活
类似于NGF和bFGF稳定转染入细胞。这
允许分子遗传策略来剖析生长的要素,
因子受体信号转导参与PC 12细胞分化。
该建议还试图2)定义NGF,bFGF和
PDGF刺激p42/44 MAP的持续磷酸化和激活
激酶在分化的PC 12细胞中的作用。重组p42 MAP激酶将在
用作蛋白激酶底物以鉴定和测定蛋白激酶
磷酸化并激活MAP激酶。此外,p54 MAP激酶
与p42/44 MAP激酶相关的p34-cdc 2蛋白激酶
将检查神经营养因子的差异调节,
有丝分裂原最后,3)p42 MAP激酶的突变形式,其可能表现出
显性阴性表型将在PC 12细胞中表达,以确定
PC 12细胞生长因子信号转导对p42/44 MAP激酶需求
细胞分化总之,这些目标将开始定义
受体周围的效应物和蛋白激酶网络
PC 12细胞中的酪氨酸激酶刺激信号导致细胞生长
和差异化。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LYNN E HEASLEY其他文献
LYNN E HEASLEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LYNN E HEASLEY', 18)}}的其他基金
Colorado HNC SPORE Career Enhancement Program
科罗拉多州 HNC SPORE 职业提升计划
- 批准号:
10268849 - 财政年份:2021
- 资助金额:
$ 9.93万 - 项目类别:
Regulation of Targeted Therapeutic Response by the Immune Microenvironment in HNSCC
HNSCC 免疫微环境对靶向治疗反应的调节
- 批准号:
9974288 - 财政年份:2019
- 资助金额:
$ 9.93万 - 项目类别:
Regulation of Targeted Therapeutic Response by the Immune Microenvironment in HNSCC
HNSCC 免疫微环境对靶向治疗反应的调节
- 批准号:
10477265 - 财政年份:2019
- 资助金额:
$ 9.93万 - 项目类别:
Regulation of Targeted Therapeutic Response by the Immune Microenvironment in HNSCC
HNSCC 免疫微环境对靶向治疗反应的调节
- 批准号:
10266070 - 财政年份:2019
- 资助金额:
$ 9.93万 - 项目类别:
An FGFR1 oncogene driver pathway in head and neck cancer
头颈癌中的 FGFR1 致癌基因驱动通路
- 批准号:
9275384 - 财政年份:2013
- 资助金额:
$ 9.93万 - 项目类别:
An FGFR1 oncogene driver pathway in head and neck cancer
头颈癌中的 FGFR1 致癌基因驱动通路
- 批准号:
8544051 - 财政年份:2013
- 资助金额:
$ 9.93万 - 项目类别:
An FGFR1 oncogene driver pathway in head and neck cancer
头颈癌中的 FGFR1 致癌基因驱动通路
- 批准号:
8814998 - 财政年份:2013
- 资助金额:
$ 9.93万 - 项目类别:
An FGFR1 oncogene driver pathway in head and neck cancer
头颈癌中的 FGFR1 致癌基因驱动通路
- 批准号:
8966650 - 财政年份:2013
- 资助金额:
$ 9.93万 - 项目类别:














{{item.name}}会员




